Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide

Biochemistry

Volumn 47, Issue 17, 2008, Pages 5006-5016

  Karr, Jesse W ^a,b   Szalai, Veronika A ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; COPPER COMPOUNDS; ENZYME ACTIVITY; MOLECULAR INTERACTIONS; MONOMERS; OLIGOMERIZATION; OLIGOMERS; PARAMAGNETIC RESONANCE; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER ISEASES; LOW TEMPERATURE ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE OLIGOMERIC STATES;

PEPTIDES;

AMYLOID BETA PROTEIN; COPPER; MONOMER; OLIGOMER;

ARTICLE; BINDING SITE; COMPLEX FORMATION; ELECTRON SPIN RESONANCE; LOW TEMPERATURE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY; ALZHEIMER DISEASE; CHEMISTRY; DRUG EFFECT; FLUORESCENCE; METABOLISM; PROTEIN QUATERNARY STRUCTURE; SOLUBILITY; TEMPERATURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; COPPER; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLUORESCENCE; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SOLUBILITY; TEMPERATURE;

EID: 42449090677     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702423h     Document Type: Article

References (87)

1. Honig, L. S., and Mayeux, R. (2001) Natural history of Alzheimer's disease. Aging (Milano, Italy) 13, 171-182.
2. Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., and Evans, D. A. (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119-1122.
3. Behl, C. (2000) Apoptosis and Alzheimer's disease. J. Neural. Transm. 107, 1325-1344.
4. Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N., and Lubec, G. (2001) Expression of apoptosis related proteins in brains of patients with Alzheimer's disease. Neurosci. Lett. 303, 79-82.
5. Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., and Cotman, C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90, 7951-7955.
6. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., Beyreuther, K., Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S., and Emmerling, M. R. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome: Morphology and toxicity of Aβ-(1-A2) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 82, 4245-4249.
7. Beauchemin, D., and Kisilevsky, R. (1998) A Method Based on ICP-MS for the Analysis of Alzheimer's Amyloid Plaques. Anal. Chem. 70, 1026-1029.
8. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
9. Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., and Barnham, K. J. (2001) Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate and Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits. J. Biol. Chem. 276, 20466-20473.
10. Garzon-Rodriguez, W., Yatsimirsky, A. K., and Glabe, C. G. (1999) Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's disease Aβ peptide studied by fluorescence. Bioorg. Med. Chem. Lett. 9, 2243-2248.
11. Mantyh, P. W., Ghilardi, J. R., Rogers, S., DeMaster, E., Allen, C. J., Stimson, E. R., and Maggio, J. E. (1993) Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61, 1171-1174.
12. Miura, T., Hori-i, A., Mototani, H., and Takeuchi, H. (1999) Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. Biochemistry 38, 11560-11569.
13. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998) Dramatic Aggregation of Alzheimer Aβ by Cu(II) is Induced by Conditions Representing Physiological Acidosis. J. Biol. Chem. 273, 12817-12826.
14. Huang, X., Cuajungco, M. P., Atwood, C. G., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999) Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity. J. Biol. Chem. 274, 37111-37116.
15. Huang, X., Atwood, C. G., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999) The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction. Biochemistry 38, 7609-7616.
16. Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., and Bush, A. I. (2002) Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid. J. Biol. Chem. 43, 40302-40308.
17. Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., and Takashima, A. (2001) New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity. J. Biol. Chem. 276, 32293-32299.
18. Hou, L., and Zagorski, M. G. (2006) NMR reveals anomalous copper(II) binding to the amyloid Aβ peptide of Alzheimer's disease. J. Am. Chem. Soc. 128, 9260-9261.
19. 2+ Inhibits the Aggregation of Amyloid β-Peptide(1-42) in vitro. Angew. Chem., Int. Ed. 40, 2274-2277.
20. Zou, K., Gong, J. S., Yanagisawa, K., and Michikawa, M. (2002) A novel function of monomeric amyloid β-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22, 4833-4841.
21. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N., Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. Mol. Pharmacol. 45, 373-379.
22. Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577.
23. 2+ Induced Aggregation and Dityrosine Formation of the Alzheimer's Disease Amyloid-β Peptide. Biochemistry 46, 2881-2891.
24. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453.
25. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84.
26. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
27. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357.
28. Walsh, D. M., and Selkoe, D. J. (2007) Aβ oligomers: A decade of discovery. J. Neurochem. 101, 1172-1184.
29. Dong, J., Atwood, C. G., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., and Carey, P. R. (2003) Metal Binding and Oxidation of Amyloid-β within Isolated Senile Plaque Cores: Raman Microscopic Evidence. Biochemistry 42, 2768-2773.
30. Syme, C. D., Nadal, R. C., Rigby, S. E. J., and Viles, J. H. (2004) Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer's Disease: Folding, Coordination Geometry, pH Dependence, Stoichiometry, and Affinity of Aβ-(1-28): Insights from a Range of Complementary Spectroscopic Techniques. J. Biol. Chem. 279, 18169-18177.
31. Miura, T., Suzuki, K., Kohata, N., and Takeuchi, H. (2000) Metal Binding Modes of Alzheimer's Amyloid β-Peptide in Insoluble Aggregates and Soluble Complexes. Biochemistry 39, 7024-7031.
32. 2+ Binding Site in Amyloid-β. Biochemistry 44, 5478-5487.
33. Kowalik-Jankowska, T., Ruta, M., Wisniewska, K., and Lankiewicz, L. (2003) Coordination abilities of the 1-16 and 1-28 fragments of β-amyloid peptide towards copper(II) ions: A combined potentiometric and spectroscopic study. J. Inorg. Biochem. 95, 270-282.
34. Zagorski, M. G., Yang, J., Shao, H., Ma, K., Zeng, H., and Hong, A. (1999) Methodological and Chemical Factors Affecting Amyloid β Peptide Amyloidogenicity. Methods Enzymol. 309, 189-204.
35. Rickard, G. A., Gomez-Balderas, R., Brunelle, P., Raffa, D. F., and Rauk, A. (2005) Binding Affinities for Models of Biologically Available Potential Cu(II) Ligands Relevant to Alzheimer's Disease: An ab Initio Study. J. Phys. Chem. A 109, 8361-8370.
36. Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., and Faller, P. (2006) Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer's disease. J. Biol. Inorg. Chem. 11, 1024-1038.
37. 2+ ion concentration. Angew. Chem., Int. Ed. 46, 3959-3961.
38. 2+ in a mononuclear metal ion binding site. J. Am. Chem. Soc. 126, 13534-13538.
39. Stine, W. B., Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622.
40. 2+ Binding Sites in the N-Terminal Domain of the Prion Protein by EPR and CD Spectroscopy. Biochemistry 39, 13760-13771.
41. Weil, J. A., Bolton, J. R., and Wertz, J. E. (1994) Electron Paramagnetic Resonance: Elementary Theory and Practical Applications, Wiley, New York.
42. LeVine, H., III (1999) Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274-284.
43. Karr, J. W., and Szalai, V. A. (2007) Role of Aspartate-1 in Cu(II) Binding to the Amyloid-β Peptide of Alzheimer's Disease. J. Am. Chem. Soc. 129, 3796-3797.
44. Moffett, J., Zika, R. G., and Petasne, R. G. (1985) Evaluation of Bathocuproine for the Spectrophotometric Determination of Copper(I) in Copper Redox Studies with Applications in Studies of Natural Waters. Anal. Chim. Acta 175, 171-179.
45. Bozzola, J. J., and Russell, L. D. (1992) Electron Microscopy: Principles and Techniques for Biologists, Jones and Bartlett Publishers, Sudbury, MA.
46. Antzutkin, O. N. (2004) Amyloidosis of Alzheimer's Aβ Peptides: Solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies. Magn. Reson. Chem. 42, 231-246.
47. Jiang, D., Men, L., Wang, J., Zhang, Y., Chickenyen, S., Wang, Y., and Zhou, F. (2007) Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance. Biochemistry 46, 9270-9282.
48. Hou, L., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. J., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Przybyla, A. B., and Zagorski, M. G. (2004) Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 126, 1992-2005.
49. Kusumoto, Y., Lomakin, A., Teplow, D. B., and Benedek, G. B. (1998) Temperature Dependence of Amyloid β-protein fibrillization. Proc. Natl. Acad. Sci. U.S.A. 95, 12277-12282.
50. LeVine, H., III (2004) Alzheimer's β-peptide oligomer formation at physiologic concentrations. Anal. Biochem. 335, 81-90.
51. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T., Jr. (1999) Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease. Biochemistry 38, 8972-8980.
52. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. G. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18.
53. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324.
54. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-Propagating, Molecular-Level Polymorphism in Alzheimer's β-Amyloid Fibrils. Science 307, 262-265.
55. Glabe, C. G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 27, 570-575.
56. Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., and Selkoe, D. J. (2006) Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: A potent role for trimers. J. Physiol. 572, 477-492.
57. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., and Glabe, C. G. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17294-17300.
58. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (2000) Characterization of copper interactions with alzheimer amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid β1-42. J. Neurochem. 75, 1219-1233.
59. Connors, K. A. (1987) Binding Constants, 1st ed., John Wiley & Sons, New York.
60. Garzon-Rodriguez, W., Yatsimirsky, A. K., and Glabe, C. G. (1999) Binding of Zn(II), Cu(II), and Fe(II) Ions to Alzheimer's Aβ Peptide Studied by Fluorescence. Bioorg. Med. Chem. Lett. 9, 2243-2248.
61. Danielsson, J., Pierattelli, R., Banci, L., and Graslund, A. (2007) High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid β-peptide. FEBS J. 274, 46-59.
62. Talmard, C., Bouzan, A., and Faller, P. (2007) Zinc Binding to Amyloid-β: Isothermal Titration Calorimetry and Zn Competition Experiments with Zn Sensors. Biochemistry 46, 13658-13666.
63. Ma, Q. F., Hu, J., Wu, W. H., Liu, H. D., Du, J. T., Fu, Y., Wu, Y. W., Lei, P., Zhao, Y. F., and Li, Y. M. (2006) Characterization of copper binding to the peptide amyloid-β(1-16) associated with Alzheimer's disease. Biopolymers 83, 20-31.
64. Ma, Q.-F., Hu, J., Wu, W.-H., Liu, H.-D., Du, J.-T., Fu, Y., Wu, Y.-W., Lei, P., Zhao, Y.-F., and Li, Y.-M. (2006) Characterization of Copper Binding to the Peptide Amyloid-β(1-16) Associated with Alzheimer's disease. Biopolymers 83, 20-31.
65. Berthon, G., Matuchansky, C., and May, P. M. (1980) Computer Simulation of Metal Ion Equilibria in Biofluids. Part 3. Trace Metal Supplementation in Total Parenteral Nutrition. J. Inorg. Biochem. 13, 63-73.
66. Hershey, C. O., Hershey, L. A., Varnes, A., Vibhakar, S. D., Lavin, P., and Strain, W. H. (1983) Cerebrospinal fluid trace element content in dementia: Clinical, radiologic, and pathologic correlations. Neurology 33, 1350-1353.
67. Palm, R., Strand, T., and Hallmans, G. (1986) Zinc, total protein, and albumin in CSF in patients with cerebrovascular diseases. Acta Neurol. Scand. 74, 308-313.
68. Yang, D. S., Yip, C. M., Huang, T. H., Chakrabartty, A., and Fraser, P. E. (1999) Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones. J. Biol. Chem. 274, 32970-32974.
69. Bocharova, O. V., Breydo, L., Salnikov, V. V., and Baskakov, I. V. (2005) Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry 44, 6776-6787.
70. Ali, F. E., Separovic, F., Barrow, C. J., Yao, S., and Barnham, K. J. (2006) Copper and zinc mediated oligomerisation of Ab peptides. Int. J. Pept. Res. Ther. 12, 153-164.
71. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., and Tycko, R. (2002) A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U.S.A. 99, 16742-16747.
72. Petkova, A. T., Yau, W. M., and Tycko, R. (2006) Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry 45, 498-512.
73. Tycko, R., and Ishii, Y. (2003) Constraints on supramolecular structure in amyloid fibrils from two-dimensional solid-state NMR spectroscopy with uniform isotopic labeling. J. Am. Chem. Soc. 125, 6606-6607.
74. Shivaprasad, S., and Wetzel, R. (2004) An Intersheet Packing Interaction in Aβ Fibrils Mapped by Disulfide Cross-Linking. Biochemistry 43, 15310-15317.
75. Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., and Wetzel, R. (2001) Structural Features of the Aβ Amyloid Fibril Elucidated by Limited Proteolysis. Biochemistry 40, 11757-11767.
76. 1-40 Amyloid Fibril Secondary Structure Using Nuclear Magnetic Resonance Spectroscopy. Biochemistry 44, 4434-4441.
77. Tycko, R. (2004) Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14, 96-103.
78. Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G., and Langen, R. (2002) Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 40810-40815.
79. Lim, K. H., Kim, Y. K., and Chang, Y.-T. (2007) Investigations of the Molecular Mechanism of Metal-Induced Aβ(1-40) Amyloidogenesis. Biochemistry 46, 13523-13532.
80. Atwood, C. G., Perry, G., Zeng, H., Kato, Y., Jones, W. D., Ling, K.-Q., Huang, X., Moir, R. D., Wang, D., Sayre, L. M., Smith, M. A., Chen, S. G., and Bush, A. I. (2004) Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β. Biochemistry 43, 560-568.
81. Barnham, K. J., Haeffner, F., Ciccotosto, G. D., Curtain, C. C., Tew, D., Mavros, C., Beyreuther, K., Carrington, D., Masters, C. L., Cherny, R. A., Cappai, R., and Bush, A. I. (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid. FASEB J. 18, 1427-1429.
82. Talmard, C., Guilloreau, L., Coppel, Y., Mazarguil, H., and Faller, P. (2007) Amyloid-β peptide forms monomeric complexes with Cu(II) and Zn(II) prior to aggregation. ChemBioChem 8, 163-165.
83. Raman, B., Ban, T., Yamaguchi, K. I., Sakai, M., Kawai, T., Naiki, H., and Goto, Y. (2005) Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide. J. Biol. Chem. 280, 16157-16162.
84. Wood, S. J., Maleeff, B., Hart, T., and Wetzel, R. (1996) Physical, Morphological and Functional Differences between pH 5.8 and 7.4 Aggregates of the Alzheimer's Amyloid Peptide Aβ. J. Mol. Biol. 256, 870-877.
85. Chen, Y. R., and Glabe, C. G. (2006) Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42: Stable trimer or tetramer formation by Aβ42. J. Biol. Chem. 281, 24414-24422.
86. Mamikonyan, G., Necula, M., Mkrtichyan, M., Ghochikyan, A., Petrushina, I., Movsesyan, N., Mina, E., Kiyatkin, A., Glabe, C. G., Cribbs, D. H., and Agadjanyan, M. G. (2007) Anti-A β 1-11 antibody binds to different β-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J. Biol. Chem. 282, 22376-22386.
87. Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A., Lind, M., and Selkoe, D. J. (1987) Synthetic peptide homologous to β protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. U.S.A. 84, 6953-6957.